Tryptophan Metabolism in Kidney Disease

Completed

• Conditions: Chronic Kidney Disease

• Registration Number: NCT00758537
• Lead Sponsor: Charite University, Berlin, Germany

Brief Summary

Tryptophan metabolism in kidney disease will be investigated in patients with chronic kidney disease stages (ADOQI 3-5). Tryptophan levels and respective catabolites will be assessed under hemodialysis.

Detailed Description

Not available

Study Timeline

• Study Start: 2007-01
• Study First Submitted: 2008-09-23
• Study First Submitted QC: 2008-09-23
• Study First Posted: 2008-09-25
• Study Completion: 2008-10
• Status Verified: 2009-07
• Last Update Submitted: 2009-07-13
• Last Update Posted: 2009-07-14

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

• Chronic kidney disease (for > 3months) stages (National Kidney foundation/ADOQI): 3-5

Exclusion Criteria

• Signs of infection or systemic inflammation

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Course of plasma tryptophan level and levels of tryptophan metabolites under standard low-flux hemodialysis.	does not apply

Trial Locations

Locations (1)

Charite University Medicine Berlin; 🇩🇪 Berlin, Germany